DiabetesGenetic & Genomic MedicinePeer-reviewed journal article
The relationship between glycaemia, cognitive function, structural brain outcomes and dementia: A Mendelian randomization study in the UK Biobank
Victoria GarfieldiD, Aliki‐Eleni FarmakiiD, Ghazaleh FatemifariD, Sophie V. EastwoodiD, Rohini MathuriD, Christopher T. RentschiD, Spiros DenaxasiD, Krishnan BhaskaraniD, Liam L SmeethiD, Nish ChaturvediiD
Abstract
AimsTo investigate the relationship between glycaemia and cognitive function, brain structure and incident dementia using bidirectional Mendelian randomisation (MR). MethodsUK Biobank (n~500,000) individuals, aged 40-69 years at baseline. Our exposures were genetic instruments for type-2 diabetes (163 variants) and HbA1c (52 variants) and our outcomes were reaction time (RT - milliseconds), visual memory (number of incorrect responses), hippocampal and white matter hyperintensity volumes (both mm3), Alzheimers disease (AD). To study potential bidirectional effects, we then investigated the associations between genetic variants for RT (43 variants) and clinical type-2 diabetes and measured HbA1c. We used conventional inverse-variance weighted (IVW) MR, alongside standard MR sensitivity analyses. ResultsUsing IVW, genetic liability to type-2 diabetes was not associated with reaction time (exponentiated {beta}=1.00, 95%CI=1.00; 1.00), visual memory (exp{beta}=1.00, 95%CI=0.99; 1.00), white matter hyperintensity volume (exp{beta}=0.98, 95%CI=0.93; 1.03), hippocampal volume (coefficient mm3=0.00, 95%CI=-0.01; 0.01) or risk of AD (OR 0.97, 95%CI=0.89; 1.06). HbA1c was not associated with reaction time (exp{beta}=1.01, 95%CI=1.00; 1.01), white matter hyperintensity volume (exp{beta}=0.88, 95%CI=0.73; 1.07), hippocampal volume (coefficient=-0.02, 95%CI=-0.10; 0.06), risk of AD (OR 0.94, 95%CI=0.47; 1.86), but HbA1c was associated with visual memory (exp{beta}=1.06, 95%CI=1.05; 1.07) using a weighted median approach. IVW showed no evidence that reaction time was associated with diabetes (OR 0.96, 95%CI=0.63; 1.46) or HbA1c (coefficient=-0.08, 95%CI=-0.57; 0.42). MR-Egger intercept p-values indicated no major issues with unbalanced horizontal pleiotropy (all p>0.05). ConclusionsOverall, we observed little evidence of causal associations between glycaemia and cognition, structural brain and dementia phenotypes. AbbreviationsAlzheimers dementia (AD) Benjamini-Hochberg false discovery rate (BH-FDR) Genome-wide association study (GWAS) Hippocampal volume (HV) Hospital episode statistics (HES) International Classification of Diseases (ICD) Inverse variance weighted (IVW) Magnetic resonance imaging (MRI) Mendelian randomization (MR) Quality control (QC) Reaction time (RT) Simulation extrapolation (SIMEX) UK Biobank (UKB) Visual memory (VM) Weighted median Estimator (WME) White matter hyperintensity volume (WMHV)
- organism: human
- assay: electronic health records
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 43
- FWCI
- 5.02
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetics-informed bidirectional mapping of glycemic traits and brain phenotypes
B Liu, Yunfan Zhang, … Chao Li·bioRxiv·Jan 8, 2026
- Evaluation of the causal associations between brain imaging-derived phenotypes and type 2 diabetes: a bidirectional Mendelian randomization study
Shan‐Shan Dong, Ke Yu, … Tie‐Lin Yang·medRxiv·Dec 16, 2022
- Diabetes mellitus, glycemic traits, and cerebrovascular disease: a Mendelian randomization study
Marios K. Georgakis, Eric L. Harshfield, … Martin Dichgans·NeurologyPeer-reviewed·Jan 25, 2021
- Cognitive ability and physical health: a Mendelian randomization study
Saskia P. Hagenaars, Catharine R. Galé, … Sarah E. Harris·Scientific ReportsPeer-reviewed·May 25, 2017
- Evaluating Diabetes Drug Targets for Vascular Dementia Prevention Using Drug Target Mendelian Randomisation
Amy E. Packer, Lauren Austin, … Emma Louise Anderson·medRxiv·Sep 29, 2026
- Obesity impairs cognitive function via metabolic syndrome and cerebrovascular disease: an SEM analysis in 15,000 adults from the UK Biobank.
Filip Morys, Mahsa Dadar, Alain Dagher·The Journal of Clinical Endocrinology & MetabolismPeer-reviewed·Mar 2, 2021